The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-sectional comparison of established screening tools in a German-Swiss population

References

• Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85:81–9.
   PubMed Web of Science ®Google Scholar
• Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry. 1984;47:953–9.
   PubMed Web of Science ®Google Scholar
• Wikström J, Paetau A, Palo J, Sulkava R, Haltia M. Classic amyotrophic lateral sclerosis with dementia. Arch Neurol. 1982;39:681–3.
   PubMedGoogle Scholar
• Ziegler LH. Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch NeurPsych. 1930; 24:930–6.
   Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
   PubMed Web of Science ®Google Scholar
• Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a Population-Based Case-Control Cohort Study of Familial and Sporadic Amyotrophic Lateral Sclerosis. Ann Neurol. 2013;74:699–708.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013; 12:368–80.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, de Visser M, Linssen WH, de Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2010; 11:27–37.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Bak TH, Hodges JR. Motor neuron disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol. 2001;248:260–70.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:67–74.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioural variant frontotemporal dementia (bvFTD). Acta Neuropathol. 2014;127:423–39.
   PubMed Web of Science ®Google Scholar
• Floris G, Borghero G, Chiò A, Secchi L, Cannas A, Sardu C, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler. 2012; 13:95–101.
   PubMed Web of Science ®Google Scholar
• Osborne RA, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014;336:191–6.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734–47.
   PubMed Web of Science ®Google Scholar
• Flaherty-Craig C, Eslinger P, Stephens B, Simmons Z. A rapid screening battery to identify frontal dysfunction in patients with ALS. Neurology. 2006;67:2070–2.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Wang Y, Doorish C, Lewis M, Battista V, Mitsumoto H, Marder K. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler. 2007;8:362–5.
   PubMed Web of Science ®Google Scholar
• Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioural Screen (ALS-CBS). Amyotroph Lateral Scler. 2010;11:303–11.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL;World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000; 55:1621–6.
   PubMed Web of Science ®Google Scholar
• Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 1988;4:642–52.
   Google Scholar
• Cohen JA. A coefficient of agreement for nominal scales. Educational and Psychological Measurement. 1960;20: 37–46.
   Web of Science ®Google Scholar
• Hallgren. Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Wuant Methods Psychol. 2012;8:23–34.
   PubMedGoogle Scholar
• Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Eurals Consortium. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Lulé D, Ehlich B, Lang D, Sorg S, Heimrath J, Kübler A, et al. Quality of life in fatal disease: the flawed judgment of the social environment. J Neurol. 2013; 260:2836–43.
   PubMed Web of Science ®Google Scholar
• Bak TH. Learning from history: FTD, ALS and behaviour. Rinsho Shinkeigaku. 2010;50:1013.
   Google Scholar
• Raaphorst J, Beeldman E, Jaeger B, Schmand B, van den Berg LH, Weikamp JG, et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Is the Frontal Assessment Battery reliable in ALS patients? Amyotroph Lateral Scler. 2013;14:73–4.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, Jaeger B, Schmand B, van den Berg LH, Weikamp JG, et al. Response to ‘Exploring limits of neuropsychological screening in ALS: The FAB problem’. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14:159–60.
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Ferrarese C, Appollonio I. Exploring limits of neuropsychological screening in ALS: the FAB problem. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14:157–8.
   PubMed Web of Science ®Google Scholar